Laboratorio de análisis Echevarne

DrugChip

DrugChip®

Genetic test that combines the study of allelic variants in metabolising genes (only Phase I), transporters and targets to provide relevant information on possible adverse reactions or the possibility of therapeutic responses.

Which patients is it most useful for?

DrugChip® offers a study of over 100 drugs. It can be requested in full or by panels segmented by specialty, which allows the test to be oriented more directly to each case.

DrugChip® Neuro

  • Neuropsychiatric disorders
  • Depression
  • Psychosis
  • Anxiety and insomnia
  • Epilepsies

DrugChip® Cardio

  • Cardiovascular disease
  • Hypertension

DrugChip® Onco

  • Different types of cancer

Benefits

Select the most appropriate drugs using the genetic information to:

Minimise side effects

Maximise therapeutic efficacy

What information does it provide?

DrugChip® analyses the two main groups of genes involved in:


PHARMACODYNAMIC PROPERTIES OF DRUGS

  • How the drug acts on our body.
  • Determine the efficacy of the drug.

PHARMACOKINETIC PROPERTIES OF DRUGS

  • How the body modifies the drug.
  • Determine the toxicity of the drug.

Other Key Tests

Consult your results